Heather L Friberg-Robertson

12PUBLICATIONS
29CO-AUTHORS
Innate immunityMajor global burdens of diseaseInfant and child healthContract lawGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 31, 2026
Evaluation of inactivated and live attenuated, tetravalent dengue vaccine prime-boost strategies in a randomized, open-label, phase I study: implications for understanding immune correlates of protection.

|Jul 10, 2026
A novel method for depletion of dengue virus non-structural protein 1 antibodies to determine serotype exposure history.

|Jun 26, 2026
A comparative analysis of the immunotranscriptomic features of DENV-1, -3, and -4 human challenge models.

|Oct 17, 2024
Long term T cell response and safety of a tetravalent dengue vaccine in healthy children.

Sanja Mandaric, Heather Friberg, Xavier Saez-Llorens

|Mar 24, 2023
Investigation of an outbreak of COVID-19 among U.S. military personnel and beneficiaries stationed in the Republic of Korea, June-July 2021.

Shilpa Hakre, Evelyn Y Lam, Irina Maljkovic-Berry

|Nov 01, 2022
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults.

Heather Friberg, Morgan Gargulak, Amanda Kong

Pageof 2

Frequent Collaborators

2 joint publications

Alan L Rothman

2 joint publications

Michael K McCracken

2 joint publications

Gregory D Gromowski

2 joint publications

Jeffrey R Currier